Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.07 (+0.71%)
TSLA   183.03 (+0.09%)
NVDA   158.20 (-2.77%)
NIO   10.13 (-0.39%)
BABA   75.90 (+0.53%)
AMD   73.17 (-2.62%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.07 (+0.71%)
TSLA   183.03 (+0.09%)
NVDA   158.20 (-2.77%)
NIO   10.13 (-0.39%)
BABA   75.90 (+0.53%)
AMD   73.17 (-2.62%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.07 (+0.71%)
TSLA   183.03 (+0.09%)
NVDA   158.20 (-2.77%)
NIO   10.13 (-0.39%)
BABA   75.90 (+0.53%)
AMD   73.17 (-2.62%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.07 (+0.71%)
TSLA   183.03 (+0.09%)
NVDA   158.20 (-2.77%)
NIO   10.13 (-0.39%)
BABA   75.90 (+0.53%)
AMD   73.17 (-2.62%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)
NASDAQ:INO

Inovio Pharmaceuticals - INO Price Target & Analyst Ratings

$1.91
-0.10 (-4.98%)
(As of 11/28/2022 03:59 PM ET)
Add
Compare
Today's Range
$1.90
$2.03
50-Day Range
$1.56
$2.50
52-Week Range
$1.38
$7.66
Volume
368,917 shs
Average Volume
5.67 million shs
Market Capitalization
$476.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.75

Inovio Pharmaceuticals Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 7 Analyst Ratings

Consensus Analyst Price Target

$3.75
96.34% Upside
High Prediction$6.00
Average Prediction$3.75
Low Prediction$2.00
TypeCurrent
11/28/21 to 11/28/22
1 Month Ago
10/29/21 to 10/29/22
3 Months Ago
8/30/21 to 8/30/22
1 Year Ago
11/28/20 to 11/28/21
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$3.75$5.75$5.75$13.17
Predicted Upside96.34% Upside60.81% Upside60.81% Upside60.28% Upside
Get Inovio Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter.


INO Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

INO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Inovio Pharmaceuticals Stock vs. The Competition

TypeInovio PharmaceuticalsMedical CompaniesS&P 500
Consensus Rating Score
1.86
2.66
2.48
Consensus RatingHoldBuyHold
Predicted Upside86.57% Upside748.83% Upside12.77% Upside
News Sentiment RatingPositive News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
714
73.99%
Underperform Votes
251
26.01%
Avg. Outperform Votes
162
66.39%
Avg. Underperform Votes
82
33.61%
Avg. Outperform Votes
851
68.13%
Avg. Underperform Votes
398
31.87%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/9/2022Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
11/1/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$2.00-7.41%
8/17/2022Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Duncan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral
7/19/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSector Perform ➝ Sector Perform$5.00 ➝ $4.00+117.39%
5/11/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
12/30/2021Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$8.00 ➝ $6.00+12.57%
12/15/2021HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold
5/10/2021Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Neutral$7.00 ➝ $6.00-10.04%
1/8/2021Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$25.00 ➝ $15.00+58.90%
11/17/2020Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Aschoff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Sell$8.00-37.74%
8/11/2020Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Stephen Willey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Target$24.00 ➝ $16.00+9.85%
1/2/2020Piper Jaffray Companies
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$10.00 ➝ $8.00+149.22%
(Data available from 11/28/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












INO Price Target - Frequently Asked Questions

What is Inovio Pharmaceuticals's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for Inovio Pharmaceuticals stock is Hold based on the current 1 sell rating and 6 hold ratings for INO. The average twelve-month price prediction for Inovio Pharmaceuticals is $3.75 with a high price target of $6.00 and a low price target of $2.00. Learn more on INO's analyst rating history.

Do Wall Street analysts like Inovio Pharmaceuticals more than its competitors?

Analysts like Inovio Pharmaceuticals less than other Medical companies. The consensus rating for Inovio Pharmaceuticals is Hold while the average consensus rating for medical companies is Buy. Learn more on how INO compares to other companies.

Do MarketBeat users like Inovio Pharmaceuticals more than its competitors?

MarketBeat users like Inovio Pharmaceuticals more than other Medical companies. 73.99% of MarketBeat users gave Inovio Pharmaceuticals an outperform vote while medical companies recieve an average of 66.12% outperform votes by MarketBeat users.

Is Inovio Pharmaceuticals being downgraded by Wall Street analysts?

Over the previous 90 days, Inovio Pharmaceuticals's stock had 2 downgrades by analysts.

Does Inovio Pharmaceuticals's stock price have much upside?

According to analysts, Inovio Pharmaceuticals's stock has a predicted upside of 24.11% based on their 12-month price targets.

What analysts cover Inovio Pharmaceuticals?

Inovio Pharmaceuticals has been rated by Bank of America, and Maxim Group in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:INO) was last updated on 11/28/2022 by MarketBeat.com Staff